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and tibial arteries as inflow
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Purpose: Use of inflow sources distal to the common femoral artery (CFA) for bypass to infrapopliteal arteries is a
compromise measure when the length of the vein is not adequate. The purpose of this study was to compare the clinical
outcome of vein infrapopliteal bypass arising from the CFA and from the distal superficial femoral or popliteal and tibial
arteries in patients with limb-threatening ischemia.
Methods: Over 13 years, 160 vein infrapopliteal vein bypass procedures (160 patients) were randomized into 2 groups, 80
with inflow arising from the CFA (group 1) and 80 with inflow from below the CFA (group 2). Patency and limb salvage
rates were assessed with the Kaplan-Meier method. All patients underwent graft surveillance at discharge and at 30 days
and 6 months after surgery, then every 6 months thereafter. Follow-up ranged from 30 days to 127 months (mean, 49
months).
Results: Groups were similar with regard to age, sex, and most atherosclerotic risk factors. Gangrene as an indication for
surgery was statistically more frequent in group 1 (73.7% vs 48.7%; P  .002), whereas nonhealing ulcer and rest pain
were statistically more frequent in group 2 (respectively, 51.2% vs 25%; P  .001 and 46.2% vs 28.7%; P  .03). No
patients died during the perioperative (30 days) period. At 1, 3, and 5 years patency and limb salvage rates were
comparable between groups, tending toward significance for the 5-year primary patency rate (73% vs 57%; P  .08).
Conclusions: In the absence of significant proximal disease, infrapopliteal revascularization arising distal to the CFA can
ensure patency and limb salvage rates statistically similar to those with use of the CFA. Moreover, procedures arising
distal to the CFA required fewer graft revisions to maintain patency of failing grafts. ( J Vasc Surg 2004;40:732-40.)Patients with limb-threatening ischemia from severe
occlusive disease of the infrapopliteal arteries with reconsti-
tution of a patent distal crural or pedal artery are excellent
candidates for distal arterial revascularization. The source
of inflow is usually the common femoral artery (CFA), but
in selected patients, generally those with diabetes in whom
obstructive disease is preferentially in the popliteal and
tibioperoneal segments, the inflow site can be the distal
superficial femoral artery (SFA) or the popliteal and tibial
arteries. In 1981 Veith et al1 first reported on the use of
grafts arising from the SFA and popliteal arteries in selected
patients with diffuse tibial artery disease, recording favor-
able 5-year patency rates. Since then, despite reluctance to
use inflow sites distal to the CFA, because of the general
belief that atherosclerotic disease progression in the more
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doi:10.1016/j.jvs.2004.07.023732distal areas could lead to graft failure, many authors have
emphasized the selective use of more distal sites as an
alternative inflow source.2-14 This strategy has facilitated
performance of vein bypass to tibial arteries by enabling the
use of suitable vein of otherwise inadequate length, thus
averting the need to resort to femorodistal prosthetic graft
revascularization, which tends to yield a poor patency rate.
All of these studies were retrospective, forming part of
larger series2-4 or involving smaller series dealing exclu-
sively with such revascularizations5-14; none of the studies,
however, were randomized.
The purpose of the present study, which, to our knowl-
edge, is the first randomized study of this issue, was to
compare the results in terms of patency and limb salvage
rates between reversed saphenous vein infrapopliteal bypass
arising from the CFA and from more distal inflow sites in
patients with limb-threatening ischemia.
METHODS
The study design was a single-center prospective ran-
domized trial, and was approved by the local ethics com-
mittee. The hypothesis was that distal revascularization
arising from inflow sites below the CFA, such as the distal
SFA or popliteal and tibial arteries, could yield better or
comparable results in terms of patency and limb salvage
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tients had rest pain or ischemic ulceration, or gangrene
limited to the heel or forefoot, from severe atherosclerotic
peripheral occlusive disease. Patients provided written in-
formed consent before enrollment in the study. To qualify
for the study, patients met the following inclusion criteria:
preoperative angiographic evidence of severe infrapopliteal
disease in the absence of any significant proximal disease,
that is, continuous arterial flow from the CFA to the distal
SFA or popliteal artery, with no more than 25% narrowing
of the transverse diameter of the proximal axial vessel,
determined on biplane, anteroposterior, and lateral angio-
graphic views; adequate homolateral or contralateral saphe-
nous vein (adequacy was defined as compliant vein greater
than 2 mm in diameter on the strength of venous mapping
at preoperative duplex scanning) long enough to reach the
CFA; and no contraindications to anticoagulation therapy.
In some patients who were elderly or in poor medical
condition, with life expectancy estimated at less than 2
years, but with a saphenous vein long enough to reach the
CFA, any stenoses narrowing the arterial lumen by 25% to
40% were considered hemodynamically insignificant, and
bypasses were inserted distal to these stenoses, if random-
ization so indicated. Patients who met these criteria were
prospectively randomized to undergo bypass with either
the CFA (group 1) or a site distal to the CFA (group 2) as
inflow source. Randomization was made using sealed
opaque envelopes. Patients who required an inflow proce-
dure concurrent with the distal revascularization or percu-
taneous transluminal angioplasty (PTA) of the SFA or
above-knee popliteal artery to treat lesions greater than 25%
before the infrapopliteal revascularization was performed
were excluded from the study. Patients with ischemic soft
tissue breakdown between the calcaneous and metatarsal
heads (plantar region) were also excluded.
Demographic data and preoperative risk factors, in-
cluding diabetes mellitus, smoking, hypertension, coronary
artery disease, and renal failure, were determined for each
patient, along with inflow and outflow sites and preopera-
tive and postoperative complications.
All patients underwent preoperative standard biplanar
arteriography to verify the clinical and vascular laboratory
diagnosis of popliteal trifurcation disease and to aid in
selection of the appropriate site for the proximal and distal
anastomoses. Runoff scores were assessed as recommended
by the Ad Hoc Committee on Reporting Standards.15
Foot care. All foot lesions were treated according to a
standard protocol. Lesions of the heel were defined as tissue
loss inferior to the malleoli and overlying the calcaneous;
forefoot lesions consisted of tissue loss overlying the meta-
tarsal heads or more distal. The clinical presentation of
ischemic heel lesions can span a wide spectrum of diseaes,
ranging from localized skin fissures extending into the
dermis to extensive necrosis of subcutaneous tissue and
Achilles tendon with underlying calcaneal osteomyelitis.
Patients with associated infection began receiving broad-
spectrum intravenous antibiotic agents after appropriate
cultures were obtained. Deep space infection was promptlydrained or debrided as needed. Open wounds were packed
with gauze impregnated with normal saline solution or
one-fourth strength povodine-iodine solution. Once active
spreading infection was adequately controlled, noninvasive
arterial studies and angiography were performed, and pa-
tients were randomized to groups 1 or 2. The revascular-
ization procedure was delayed until cellulitis or lymphangi-
tis had disappeared from any areas of proposed surgical
incision. After revascularization, local wound care was con-
tinued. Whenever possible, foot wounds were closed defin-
itively with various procedures before discharge from the
hospital. Patients with digital gangrene or osteomyelitis
underwent toe amputation. Extensive gangrene involving
multiple toes or the distal forefoot was treated with trans-
metatarsal amputation. Patients with plantar ulcers involv-
ing metatarsal heads underwent metatarsal head resection
and ulcer excision with primary closure. Ulcers or soft tissue
defects deemed too large to heal within a reasonable time
with secondary intention were closed with split-thickness
skin grafts. In patients with heel lesions that showed calca-
neal exposure and presumed osteomyelitis, primary therapy
consisted of partial calcanectomy with primary wound clo-
sure; if the skin loss was too extensive for primary closure,
skin edges were approximated with retention sutures, and
the remaining defect was allowed to heal by secondary
intention.
Operative technique. All revascularization proce-
dures were performed by a single surgeon, with use of
regional anesthesia, either epidural or spinal, and intrave-
nous administration of heparin (5000 IU) before clamping;
heparinization was not reversed with protamine. Reversed
autogenous homolateral or contralateral saphenous vein
grafts were used in all procedures. All revascularization
procedures in group 2 were performed using saphenous
vein harvested from the groin to the thigh down to the
knee; thus the distal vein graft configuration was the same
in all patients. The randomly selected inflow artery was
exposed in standard fashion. Distal exposure methods var-
ied, depending on the vessel chosen for the bypass proce-
dure. The peroneal artery was always exposed with a lateral
approach requiring segmental fibulectomy. The dorsalis
pedis artery was often chosen as the outflow target artery in
preference to a patent peroneal artery and when no tibial
vessels were in direct continuity with the foot, but revascu-
larization to the dorsalis pedis artery was avoided in cases of
severe dorsal foot infection. After proximal and distal arte-
rial exposure the distal anastomosis was performed first. All
distal anastomotic sites underwent standard vein patch
angioplasty no longer than 3 cm, as described.16 The vein
for the patch was harvested from any available location,
including saphenous remnants, arm veins harvested with
use of local anesthesia, and occasionally also collateral ves-
sels of the saphenous vein. When the inflow source was an
infrageniculate artery, we used the same techniques for the
proximal anastomosis as are currently used to construct
distal anastomoses to crural and pedal arteries, avoiding any
dissection and clamping injuries, and vein patching at the
anastomotic site, as reported in a recent article on the
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fied distal arteries.17 Twenty-two bypasses (14%) in this
series were implanted in such unclampable vessels. When
the anterior tibial artery or the peroneal artery was used as
the outflow vessel the vein graft was always routed through
the interosseous membrane, whereas it was routed in stan-
dard fashion when the posterior tibial artery was used. A
heparin infusion was started 6 to 10 hours postoperatively,
with warfarin sodium (Coumadin) administered orally on
the first postoperative day. Long-term anticoagulation
treatment with warfarin sodium was continued for 6
months, with the goal of achieving an international normal-
ized ratio between 2 and 4. After 6 months, patients took
325 mg of aspirin daily.
Graft surveillance. End points of the study were pri-
mary, “assisted” primary, and secondary patency, limb sal-
vage rates, and death. Postoperative evaluations included
clinical examinations with pulse volume recordings, supple-
mented with duplex scanning and ankle-brachial index
(ABI) measurements in all patients at discharge, at 30 days
and 6 months after surgery, then every 6 months thereafter.
Follow-up always included color duplex scanning of the
inflow artery, the entire vein conduit, both anastomoses,
and the initial tract of the outflow artery. Graft patency
assessment was based on the presence of a palpable distal
pulse or the ABI measurement, or a patent graft on the
duplex scan. An ABI decrease of more than 0.15 compared
with the initial postoperative ABI was considered to indi-
cate a failing graft. Similarly, an abnormal duplex ultra-
sound scan was defined by the finding of focal peak systolic
flow velocity greater than 200 cm/s, velocity ratio exceed-
ing 2.0, or global graft flow velocity uniformly less than 45
cm/s. The absence of color flow in the grafts was indicative
of graft occlusion. Primary patency was defined as uninter-
rupted patency of the original graft without any further
intervention; assisted primary patency was defined as pa-
tency assisted by simple measures, primarily PTA or patch
angioplasty, with the original graft remaining free of
thrombosis; and secondary patency was defined as patency
of the original graft that was thrombosed but kept patent by
means of thrombectomy, thrombolytic therapy, PTA,
patch graft angioplasty, and proximal or distal graft exten-
sion. The graft was thus considered failing if ischemic
symptoms returned despite a palpable pulse or if changes in
Doppler signal suggested stenosis along the conduit or
occlusion. Patients with failing grafts underwent repeat
arteriography and bypass revision when possible. The graft
was regarded as failed if the occluded graft could not be
salvaged and was replaced with a new graft. Patency data for
patients who died stopped at the last time the graft was
found to be patent. Each end point was taken as the
midpoint in the interval between when the graft had last
been documented as patent and when it was revised or
clearly shown to be occluded. Limb salvage was defined as
preservation of the affected limb, with no need for ampu-
tation above the metatarsal level. An attempt was made to
make all criteria used for this analysis conform to the
standards suggested by the Ad Hoc Committee of the JointCouncil of Vascular Societies for Reports Dealing with
Lower Extremity Ischemia.15
Statistical analysis. Continuous data were compared
with the Student t test. Frequencies and categorical data
were compared with the 2 or Fisher exact test, as appro-
priate. A Cox proportional hazard model was used to
determine which factors could influence bypass graft pa-
tency and limb salvage. All tests were 2-tailed. Statistical
significance was inferred at P  .05. Primary, assisted
primary, and secondary patency rates, and limb salvage rates
for both groups were assessed with the Kaplan-Meier
method, and the Mantel-Cox log-rank test was used to
compare survival curves between groups.
RESULTS
Over 13 years, 160 patients met the inclusion criteria
for this study. Eighty procedures each were randomized to
groups 1 and 2. Follow-up ranged from 30 days to 127
months (mean, 49 months). No patients were lost to
follow-up. Overall, there were 5 elderly or sickly patients
with inflow stenosis between 25% and 40%, 4 in group 1
and 1 in group 2. Patient demographic data for the 2
groups are given in Table I. The groups were similar in
terms of age, sex, and atherosclerotic risk factors, except for
a statistically higher incidence of previous stroke in group 1
(21.2% vs 5%; P .004). Although the incidence of diabe-
tes mellitus was higher in group 2 (86.2% vs 82.5%), the
difference was not significant. Most patients had multiple
indications for surgery; gangrene was statistically more
frequent in group 1 (73.7% vs 48.7%; P  .002), whereas
nonhealing ulcer and rest pain were statistically more fre-
quent in group 2 (respectively, 51.2% vs 25%; P .001 and
46.2% vs 28.7%; P  .03; Table II). The homolateral
greater saphenous vein was used in 121 revascularization
procedures (75.6%), 56 (70%) in group 1 and 65 (81%) in
group 2 (P .14). The inflow arteries used in group 2 were
the distal SFA (19 of 80; 23.7%), the tibioperoneal trunk (4
of 80; 5%), the posterior tibial artery (3 of 80; 3.7%), and
the popliteal artery (54 of 80; 67.5%) in the above-knee (19
of 80; 23.8%) and below-knee (35 of 80; 43.7%) locations.
The runoff scores were comparable between groups; there
were no significant differences in terms of distal outflow
site, although the dorsalis pedis artery was used in more
than half of the revascularization procedures in group 2
(57.5% vs 43.8%; P .11; Table II). Although preoperative
additional foot care procedures were more frequent in
group 1, the difference was not significant (Table III).
Perioperative results. Additional postoperative foot
care procedures are shown in Table III. No patients died
during the perioperative (30 days) period. Perioperative
complication rates were comparable in the 2 groups (Table
IV). The 30-day graft patency rate was 98% and 99%,
respectively, in groups 1 and 2.
Long-term results. Primary patency results are shown
in Fig 1. At 1, 3, and 5 years they were 86%, 72%, and 57%
for group 1, and 90%, 79%, and 73% for group 2 (P .08).
At 1, 3, and 5 years, assisted primary patency rates were
91%, 83%, and 71% for group 1, and 91%, 84%, and 78% for
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3 in group 2) were detected at duplex scannng and con-
firmed at traditional angiography, and were intrinsic vein
graft defects equally dispersed throughout the length of the
vein graft. Graft revisions involved PTA, patch angioplasty,
or insertion of a new graft segment. Secondary patency was
successfully restored in 12 grafts in group 1 and in 7 grafts
in group 2. Most of these grafts (8 in group 1, 5 in group 2)
had failed as a result of outflow disease secondary to either
myointimal proliferation and hyperplasia or progressive
atherosclerotic lesions. In group 1 the outflow vessels in-
volved were the anterior tibial (n 3), posterior tibial (n
4), and dorsalis pedis (n  1) arteries. Graft patency was
restored with thrombectomy or lysis, and distal extension
Table I. Demographic data and risk factors
Group 1
n %
Patients 80
Procedures 80
Age (y)
Mean 68.8
Range 47-90
Men 58 72.5
Risk factors
Diabetes mellitus 66 82.5
Diet controlled 8 10
Oral agent 22 27.5
Insulin-dependent 36 45
Smoking* 69 86.2
CAD 38 47.5
Previous MI 24 30
Previous CABG 18 22.5
Previous stroke 17 21.2
Hypertension‡ 49 61.2
Creatinine 2.0 mg/dL 4 5
Dialysis 7 8.8
CAD, Coronary artery disease; MI, myocardial infarction; CABG, coronary
*Defined by patient history.
†Fisher exact test.
‡Defined as blood pressure treated with medication.
Table II. Indications for surgery and outflow target arteri
Group 1
n %
Indications for surgery
Gangrene 59 73.7
Nonhealing ulcer 20 25
Rest pain 23 28.7
Infection 19 23.7
Outflow target arteries
Tibioperoneal trunk 6 7.5
Anterior tibial 10 12.5
Posterior tibial 20 25
Peroneal 9 11.2
Dorsalis pedis 35 43.8
Tarsal/plantar 0
*Fisher exact test.with a “jump” vein graft. In group 2 patency was restored
in 3 below-knee popliteal-anterior tibial artery bypasses
with a jump vein graft to the dorsalis pedis artery, 17, 23,
and 29 months after surgery. In another 2 procedures
revision involved detaching the saphenous vein close to the
vein patch, which was removed. The recipient vessel was
then thrombectomized until satisfactory runoff was ob-
served. A new vein patch was sutured to the outflow artery,
and the original thrombectomized or lysed saphenous vein
graft was reimplanted in the patch, with no need to perform
a more caudal anastomosis. The remaining 6 failed bypasses
(4 in group 1, 2 in group 2) were thrombectomized or
lysed, with no underlying anatomic defect and no athero-
sclerotic disease proximal to the vein bypass emerging as
Group 2 Total
P% n %
80 160
80 160
70.4 .70
55-87
1 76.3 119 74.4 .71
9 86.2 135 84.4 .66
5 6.2 13 8.1 .56
8 22.5 40 25 .58
6 57.5 82 51.2 .15
0 75 129 80.6 .10
2 40 70 43.7 .42
2 27.5 46 28.7 .86
5 18.8 33 20.6 .69
4 5 21 13.1 .004†
2 65 101 63.1 .74
1 13.8 15 9.3 .10
7 8.8 14 8.8 1
bypass grafting.
Group 2 Total
P% n %
48.7 108 67.5 .002*
51.2 61 38.1 .001*
46.2 60 37.5 .03*
35 47 29.4 .16
1.2 7 4.4 .11
13.8 21 13.2 1
15 32 20 .16
7.5 15 9.3 .59
57.5 81 50.6 .11
5 4 2.5 .12n
6
6
1
4
6
3
2
1
5
1
arteryes
n
39
41
37
28
1
11
12
6
46
4
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patency rates were 95%, 93%, and 88% for group 1, and
95%, 94%, and 89% for group 2 (P  .18; Fig 3).
Nine below-knee and 3 above-knee amputations (15%)
were performed in group 1, as opposed to 7 below-knee
and 2 above-knee amputations (10%) in group 2. Overall, 5
major amputations (3 in group 1, 2 in group 2) were
needed to treat chronic neuropathic heel ulcer (n 2) and
progressive ascending gangrene (n  3) despite a patent
graft. At 1, 3, and 5 years resulting limb salvage rates were
95%, 86%, and 82% for group 1, and 95%, 89%, and 87% for
group 2 (P  .46; Fig 4). Cox analysis showed no signifi-
cant influence from the risk factors considered (smoking,
diabetes mellitus, hypertension, renal failure) or the out-
flow target vessels and indication for surgery on bypass graft
patency or limb salvage rates in the 2 groups. Overall, there
were 69 late deaths (43%), 33 in group 1 and 29 in group 2.
The 5-year patient survival rate was 59% in group 1 and 64%
in group 2 (P  .54).
DISCUSSION
The results of this prospective randomized trial indicate
that in patients with limb-threatening ischemia and occlu-
Table III. Preoperative and postoperative additional foot
Group 1
n %
Preoperative
Local procedures
Debridement 4 5
Drainage 8 10
Postoperative
Local procedures
Drainage 4 5
Debridement/STSG 6 3.7
Metatarsal head resection 17 21.2
Minor amputation
Toe(s) 22 27.5
Transmetatarsal 9 11.2
Partial calcanectomy 8 10
STSG, Split-thickness skin graft.
Table IV. Systemic and local perioperative complications
Group 1
n %
Systemic complications
Nonfatal MI 2 2.5
Heart failure 1 1.2
Pneumonia 0
Arrhythmia 6 7.5
Urinary tract infection 7 8.7
Renal failure 2 2.5
Local complications
Hematoma 9 11.2
Lymphocele 4 5
Wound dehiscence 4 5
MI, Myocardial infarction.sive lesions limited to tibial arteries, a pattern particularly
prevalent in patients with diabetes mellitus, saphenous vein
infrapopliteal revascularization originating from the SFA or
popliteal and tibial arteries can be carried out with patency
and limb salvage rates statistically no different from those
achieved with revascularization arising from the CFA.
However, the crude rates were better or equal for the
procedures arising distal to the CFA in all analyses, with a
slight trend toward significance in the 5-year primary pa-
tency rate (75% vs 57%; P  .08). These findings are
consistent with many earlier retrospective reports dealing
exclusively with the durability of procedures using nondis-
eased popliteal or tibial arteries as an alternative inflow
source (Table V).5,7-14 Other authors have also reported
similarly favorable results after comparing overall cumula-
tive patency and limb salvage rates for infrapopliteal revas-
cularizations arising from the CFA or from sites distal to the
CFA.1,3 In 1981, in a comparison between grafts to the
infrageniculate arteries, 129 from the CFA and 79 from the
distal SFA or popliteal arteries, Veith et al1 found 5-year
cumulative patency rates of 50% and 58%, respectively,
revealing a statistically insignificant difference. When vein
bypass alone was considered, patency rates were still unin-
procedures
Group 2 Total
Pn % n %
2 2.5 6 3.7 .68
3 3.7 11 6.8 .21
2 2.5 6 3.7 .68
6 3.7 12 7.5 1
21 26.2 38 23.7 .58
26 30.5 48 30 .60
13 16.2 22 13.7 .49
6 3.7 14 8.7 .78
Group 2 Total
P% n %
5 6 3.7 .68
1.2 2 1.2 1
2.5 2 1.2 .49
7.5 12 7.5 1
3.7 10 6.2 .34
1.2 3 1.8 1
8.7 16 10 .79
0 4 2.4 .12
2.5 6 3.7 .68caren
4
1
2
6
3
1
7
2
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procedures. In 1986 Sidawy et al3 retrospectively compared
the patency of 49 infrapopliteal bypass grafts originating
from the CFA with 27 bypass grafts originating from the
distal SFA or popliteal artery; the 3-year patency rate was
74% in the first group and 81% in the second group, but the
difference was not statistically significant. The non-pro-
spective, non-randomized nature of all of these studies
prevented the findings from providing conclusive proof
that distal vein bypass with more distal inflow sources could
achieve patency rates better than or equal to similar by-
passes arising from the CFA.
Fig 1. Kaplan-Meier life table analysis of primary paten
each interval is shown for each group. Percentages on th
groups; the difference did not reach significance (P  .0
7.6%, and for group 2 is 0% to 6.4%.
Fig 2. Kaplan-Meier life table analysis of “assisted” prim
at risk for each interval is shown for each group. Percen
months for the groups; the difference was not statisticall
for group 1 is 0% to 7.1%, and for group 2 is 0% to 5.9%The incidence of in-vein graft stenoses was higher in
group 1 than in group 2 (8 vs 3), which supports the
hypothesis that saphenous vein length might influence the
patency of infrapopliteal vein bypass procedures. In a ret-
rospective study of 237 consecutive reversed saphenous
vein bypasses performed in 215 patients, Ascer et al6 re-
ported a superior 5-year patency rate for short infragenicu-
late saphenous vein bypasses. Because the discrepant results
between long and short saphenous vein revascularizations
cannot be explained by differences in patient population or
by the extent of the distal arterial occlusive disease, the
authors suggested that probably the better patency of short
es between groups 1 and 2. Number of limbs at risk for
ht represent primary patency rates at 60 months for the
ange of standard errors for patency for group 1 is 0% to
atency rates between groups 1 and 2. Number of limbs
on the right represent the primary patency rates at 60
ificant (P  .45 ). Range of standard errors for patencycy rat
e rig
8). Rary p
tages
y sign
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saphenous vein. Long segments of saphenous vein, when
located in restricted outflow segments, may be more ex-
posed to graft failure, because of the longer contact of
blood with the vein, with its possibly damaged inner sur-
face.6 Another intrinsic consequence of a longer graft
might be predisposition of the vein for fibrotic stenoses, the
potential sites for which may be directly proportional to
graft length.6
None of the late graft failures in the present study
appeared to be related to progression of inflow disease.
Conversely, outflow disease secondary to myointimal pro-
Fig 3. Kaplan-Meier life table analysis of secondary pate
each interval is shown for each group. Percentages on the
groups; the difference was not statistically significant (P
is 0% to 4.6%, and for group II is 0% to 4.6%.
Fig 4. Kaplan-Meier life table analysis of limb salvage ra
interval is shown for each group. Percentages on the righ
the difference was not statistically significant (P  .46).
5.5%, and for group 2 is 0% to 4.4%.liferation and hyperplasia or to progressive atherosclerotic
lesions or unknown causes, probably related to a transient
decline in flow in a vascular bed with poor runoff, ac-
counted for all failures in groups 1 and 2. This is an
important finding because, although distal revasculariza-
tions arising below the CFA (eg, at distal SFA or popliteal
and tibial artery levels) have proved an effective alternative
to standard distal bypasses originating from the CFA, some
concern remains as to the durability of such procedures, in
the belief that any progression of atherosclerotic disease in
the SFA or popliteal and tibial arteries will subsequently
lead to graft failure. In the study by Veith et al,1 however,
tes between groups 1 and 2. Number of limbs at risk for
t represent secondary patency rates at 60 months for the
). The range of standard errors for patency for group 1
tween groups 1 and 2. Number of limbs at risk for each
esent the limb salvage rates at 60 months for the groups;
ange of standard errors for patency for group 1 is 0% toncy ra
righ
 .93tes be
t repr
The r
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distal SFA or popliteal arteries was thought to be due to
progressive stenosis in the SFA. Other groups subsequently
came to the same conclusions,7,9,10 challenging the as-
sumption that inflow for bypasses to the infrapopliteal
arteries should ideally arise from the CFA, and confirming
that in the absence of proximal disease distal revasculariza-
tions arising from sites below the CFA rarely pose a signif-
icant threat to the durability of such procedures.
Further features of this study were that the surgical
technique involved standard vein patching of all distal
anastomotic sites and of all proximal infrapopliteal anasto-
motic sites, and subsequent implantation of the vein graft in
the patch; and all patients received adequate anticoagula-
tion therapy. To our knowledge, no other authors, apart
from Linton and Wilde,18 who were the first to describe the
use of autogenous vein patches to overcome technical
difficulties encountered in anastomosing small-caliber,
thin-walled vein conduits to thick-walled diseased arteries,
have reported the use of venous patch angioplasty at distal
anastomotic levels when the conduit was the autologous
saphenous vein. Coumadin therapy is often described as
important in improving the patency rates of bypass pros-
thetic grafts in patients needing arterial reconstruction to
infrapopliteal vessels,19-21 whereas the benefit of anticoag-
ulation therapy in patients who have undergone venous
distal revascularization remains to be clearly demonstrat-
ed.22 Inasmuch as we used both vein patch angioplasty and
anticoagulation therapy in all distal revascularization pro-
cedures, we are unable to establish the influence of each of
these factors in improving patency rates.
Limb salvage rates were higher than the corresponding
primary patency rates at all intervals in both groups, which
demonstrates that the true measure of graft efficacy is its
effect on limb salvage, because many grafts may fail but
enable adjunctive wound or ulcer healing before failure.5
On the other hand, some poorly collateralized limbs
proved graft-dependent, and required major amputation
shortly after bypass failure. Also, nearly a fourth (5 of 21) of
all major amputations performed were because of chronic
neuropathic heel ulcer or progressive ascending gangrene
despite a widely patent infrapopliteal revascularization.
Although nearly 90% of our patients had diabetes, there
were no perioperative deaths, and overall cardiac morbidity
Table V. Revascularizations to infrapopliteal vessels arisin
Author Year
No. of
procedures
No. of
patients
30-Day
mortality (%)
Cantelmo5 1986 32 30 0
Rosenbloom7 1988 49 46 0
Wengerter8 1992 153 138 3.9
Marks9 1992 32 29 6.9
Brown10 1994 52 51 2
Mills11 1994 56 53 5.4
Ballard12 1995 43 40 2
Shah13 1995 106 96 2.8
Reed14 2002 249 217 2
Present study 2004 80 80 0was low (4.9%; 3.7% in group 1 vs 6.2% in group 2), thus
disproving the conviction that diabetes mellitus is a risk
factor for perioperative cardiac complications.23 Moreover,
inasmuch as multivariate analysis showed no significant
influence of diabetes mellitus on saphenous vein bypass
patency and limb salvage rates, in the series overall or in
either of the 2 groups, this study further supports the
concept that diabetes mellitus alone does not portend a
worse outcome for arterial reconstructive surgery.24-27
The dorsalis pedis artery was used as the inflow target
artery in just over half (81 of 160; 50.6%) of our revascu-
larization procedures, mainly in group 2 (46 of 80; 57.5%);
although it was once considered unsuitable because of its
distal location and small size, and because of the proximity
of preexisting infection and higher wound complication
rates,28 this study confirms the favorable results reported by
other authors.27 Moreover, revascularization to the dorsalis
pedis artery is sometimes inevitable, because in many pa-
tients with diabetes ravaged by severe infrapopliteal athero-
sclerotic disease only the foot vessels, and the dorsalis pedis
artery in particular, remain disease-free.29,30
In conclusion, this prospective randomized study offers
a useful comparison of patency and limb salvage rates in
distal arterial reconstructions arising from the CFA or from
sites distal to the CFA, providing evidence that the inflow
source does not influence the durability of the revascular-
ization in suitably selected patients. The major shortcom-
ing of this study is the inadequacy of the sample size to
enable detection of differences with adequate power be-
tween groups, so that some might be tempted to interpret
the data emerging from our trial as meaning that there is no
clinically significant difference between the 2 procedures.
However, there were one third more vein graft failures in
group 1 than in group 2 (27 vs 18), and twice the number
of revisions were needed to restore patency of the conduits
(nearly 3 times as many if we consider the assisted primary
patency [8 vs 3], and nearly twice as many for secondary
patency [12 vs 7]). Therefore, given comparable perioper-
ative complications between the 2 groups, we believe it
would not be misleading to suggest that a saphenous vein
bypass arising below the CFA may be justified even when
the saphenous vein is long enough to reach the CFA.
m superficial femoral artery or popliteal and tibial arteries
ear primary
ncy rate (%)
Extended patency (%)
(years of follow-up)
Limb salvage (%)
(years of follow-up)
79 62 (5) 79 (5)
83 41 (5) 69 (6)
71 55 (5) 73 (5)
97 63.5 (5) 79 (4)
82 75 (5) 87 (5)
90 84 (3) 77 (3)
86 55 (5) 55 (5)
91 75 (5) 93 (5)
72 62 (5) 79 (5)
90 73 (5) 87 (5)g fro
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